KABAKOFF DAVID S - 18 Jun 2026 Form 4 Insider Report for NextCure, Inc. (NXTC)

Reporting relationship: Director
Issuer ticker: NXTC
Reported as of: 18 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 Jun 2026, 16:14:56 UTC
Prior SEC filing: 24 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Steven P. Cobourn, as attorney-in-fact for David S. Kabakoff

Key filing fact

KABAKOFF DAVID S filed Form 4 for NextCure, Inc. (NXTC) on 22 Jun 2026.

Key facts

This page summarizes KABAKOFF DAVID S's Form 4 filing for NextCure, Inc. (NXTC).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 22 Jun 2026, 16:14.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

CIK 0001024008 Primary reporting owner

Relationship: Director
Address: C/O NEXTCURE, INC., 9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE
Signature: /s/ Steven P. Cobourn, as attorney-in-fact for David S. Kabakoff
Signature date: 22 Jun 2026

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NXTC transaction Derivative

Award

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 1 footnote

Footnote F1

The option vests in full on the earlier of June 18, 2027 and the date of the 2027 Annual Meeting of Stockholders.